PolyPeptide has produced its report for the period 1 January 2023 to 31 December 2023 with reference to the GRI Standards.
GRI 1 used |
GRI 1: Foundation 2021 |
Applicable GRI Sector Standard(s) |
None |
GRI Standard |
Disclosure |
Reference/ information |
Article links |
Omission |
||
|
|
|
|
|
|
|
The organization and its reporting practices |
||||||
GRI 2: General Disclosures 2021 |
2-1 |
Organizational details |
• |
Profile, page 7 |
|
|
• |
Strategy, page 9 |
|
||||
• |
Group structure and shareholders, page 58 |
|
||||
• |
Notes to the consolidated financial statements, page 176 |
|
||||
2-2 |
Entities included in the organization’s sustainability reporting |
• |
Sustainability approach, page 19 |
|
||
• |
Group structure and shareholders, page 58 |
|
||||
2-3 |
Reporting period, frequency and contact point |
• |
Introduction, page 18 |
|
||
• |
Imprint, page 220 |
|
||||
2-4 |
Restatements of information |
• |
n/a (first report) |
|
|
|
2-5 |
External assurance |
• |
Independent practitioner's limited assurance report on selected non-financial information 2023, page 52 |
|
||
|
|
|
|
|
|
|
Activities and workers |
||||||
GRI 2: General Disclosures 2021 |
2-6 |
Activities, value chain and other business relationships |
• |
Strategy, page 9 |
|
|
2-7 a., c., d., e. |
Employees |
• |
People, page 36-39 |
|
||
|
|
|
|
|
|
|
Governance |
||||||
GRI 2: General Disclosures 2021 |
2-9 |
Governance structure and composition |
• |
Board of Directors, page 67 |
|
|
2-10 |
Nomination and selection of the highest governance body |
• |
Election and term of office, page 77 |
https://report.polypeptide.com/ar/23/en/?p=1477/#bodelectionandtermofoffice |
|
|
• |
Remuneration and Nomination Committee, page 83 |
https://report.polypeptide.com/ar/23/en/?p=1477/#remunerationnomination |
|
|||
2-11 |
Chair of the highest governance body |
• |
Members of the Board of Directors, page 68 |
https://report.polypeptide.com/ar/23/en/?p=1477/#membersofthebod |
|
|
• |
Internal organizational structure, page 78 |
https://report.polypeptide.com/ar/23/en/?p=1477/#internalorganizationalstructure |
|
|||
2-12 |
Role of the highest governance body in overseeing the management of impacts |
• |
Responsibilities and organization, page 19 |
https://report.polypeptide.com/ar/23/en/?p=1808/#responsibilitiesandorganization |
|
|
2-13 |
Delegation of responsibility for managing impacts |
• |
Responsibilities and organization, page 19 |
https://report.polypeptide.com/ar/23/en/?p=1808/#responsibilitiesandorganization |
|
|
2-14 |
Role of the highest governance body in sustainability reporting |
• |
Responsibilities and organization, page 19 |
https://report.polypeptide.com/ar/23/en/?p=1808/#responsibilitiesandorganization |
|
|
2-15 |
Conflicts of interest |
• |
Internal organizational structure, page 78 |
https://report.polypeptide.com/ar/23/en/?p=1477/#internalorganizationalstructure |
|
|
|
|
|
|
|
|
|
|
2-16 |
Communication of critical concerns |
• |
Organizational Regulations |
|
|
• |
Business ethics and compliance, page 39-41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliance |
|
|||
• |
Information and control instruments vis-à-vis the Executive Committee, page 89-90 |
|
||||
2-17 |
Collective knowledge of the highest governance body |
• |
Board of Directors, page 67 |
|
||
2-18 |
Evaluation of the performance of the highest governance body |
• |
Remuneration Report, page 112 |
|
||
2-19 |
Remuneration policies |
• |
Articles of Association |
https://www.polypeptide.com/investors/results-center/results-2023/ |
|
|
2-20 |
Process to determine remuneration |
• |
Role and activities of the Board of Directors and shareholders, page 115-116 |
|
||
• |
Role and activities of the Remuneration and Nomination Committee, page 117-118 |
|
||||
|
|
|
|
|
|
|
Strategy, policies and practices |
||||||
GRI 2: General Disclosures 2021 |
2-22 |
Statement on sustainable development strategy |
• |
Editorial, page 4 |
|
|
2-23 |
Policy commitments |
• |
Business ethics and compliance, page 40 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliance |
|
|
2-24 |
Embedding policy commitments |
• |
Business ethics and compliance, page 40-41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliance |
|
|
2-25 |
Processes to remediate negative impacts |
• |
Compliance controls, page 92 |
https://report.polypeptide.com/ar/23/en/?p=1477/#compliancecontrols |
|
|
2-26 |
Mechanisms for seeking advice and raising concerns |
• |
Compliance controls, page 92 |
https://report.polypeptide.com/ar/23/en/?p=1477/#compliancecontrols |
|
|
2-27 |
Compliance with laws and regulations |
• |
Business ethics and compliance, page 39-40 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliance |
|
|
2-28 |
Membership associations |
• |
Stakeholder engagement, page 21 |
https://report.polypeptide.com/ar/23/en/?p=1808/#stakeholderengagement |
|
|
|
|
|
|
|
|
|
Stakeholder engagement |
||||||
GRI 2: General Disclosures 2021 |
2-29 |
Approach to stakeholder engagement |
• |
Stakeholder engagement, page 22 |
https://report.polypeptide.com/ar/23/en/?p=1808/#stakeholderengagement |
|
2-30 |
Collective bargaining agreements |
• |
People, page 36 |
|
||
|
|
|
|
|
|
|
GRI Standard |
Disclosure |
Reference/ information |
Article links |
Omission |
||
|
|
|
|
|
|
|
|
||||||
GRI 3: Material Topics 2021 |
3-1 |
Process to determine material topics |
• |
Identification of material topics, page 23 |
https://report.polypeptide.com/ar/23/en/?p=1814/#identificationofmaterialtopics |
|
3-2 |
List of material topics |
• |
Materiality matrix, page 24 |
https://report.polypeptide.com/ar/23/en/?p=1814/#materialitymatrix |
|
|
|
|
|
|
|
|
|
Product responsibility |
||||||
GRI 3: Material Topics 2021 |
3-3 |
Management of material topics |
• |
Product responsibility, page 27 |
https://report.polypeptide.com/ar/23/en/?p=1811/#productresponsibility |
|
Own indicator |
– |
Revenue structure |
• |
Product responsibility, page 28 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleresponsibilityachievements2023 |
|
Own indicator |
– |
Project pipeline |
• |
Product responsibility, page 28 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleresponsibilityachievements2023 |
|
Own indicator |
– |
Generics portfolio |
• |
Product responsibility, page 28 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleresponsibilityachievements2023 |
|
Own indicator |
– |
Delivery performance |
• |
Product responsibility, page 29 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleresponsibilityachievements2023 |
|
Own indicator |
– |
Customer satisfaction |
• |
Product responsibility, page 29 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleresponsibilityachievements2023 |
|
|
|
|
|
|
|
|
Green chemistry |
||||||
GRI 3: Material Topics 2021 |
3-3 |
Management of material topics |
• |
Green chemistry, page 29 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistry |
|
GRI 303: Water and Effluents 2018 |
303-5, a. |
Water consumption |
• |
Green chemistry, page 31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryachievements2023 |
|
Own indicator |
– |
Solvent consumption |
• |
Green chemistry, page 31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryachievements2023 |
|
Own indicator |
– |
Green solvent projects |
• |
Green chemistry, page 31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryachievements2023 |
|
Own indicator |
– |
Percolation deployment |
• |
Green chemistry, page 31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryachievements2023 |
|
|
|
|
|
|
|
|
Climate change mitigation |
||||||
GRI 3: Material Topics 2021 |
3-3 |
Management of material topics |
• |
Climate change mitigation, page 32 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigation |
|
GRI 302: Energy 2016 |
302-1, c.i. |
Energy consumption within the organization |
• |
Climate change mitigation, page 33-34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationachievements2023 |
|
GRI 305: Emissions 2016 |
305-1 |
Direct (Scope 1) GHG emissions |
• |
Climate change mitigation, page 34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationachievements2023 |
|
305-2 |
Energy indirect (Scope 2) GHG emissions |
• |
Climate change mitigation, page 34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationachievements2023 |
|
|
305-3 |
Other indirect (Scope 3) emissions |
• |
Climate change mitigation, page 34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationachievements2023 |
|
|
Own indicator |
– |
Renewable electricity |
• |
Climate change mitigation, page 33 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationachievements2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supply chain engagement |
||||||
GRI 3: Material Topics 2021 |
3-3 |
Management of material topics |
• |
Supply chain engagement, page 34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagement |
|
Own indicator |
– |
Supplier assessment |
• |
Supply chain engagement, page 34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementachievements2023 |
|
|
|
|
|
|
|
|
People |
||||||
GRI 3: Material Topics 2021 |
3-3 |
Management of material topics |
• |
People, page 36 |
|
|
GRI 403: Occupational health and safety 2018 |
403-9, a. ii. |
Work-related injuries |
• |
People, page 37 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
Own indicator |
– |
Employee engagement |
• |
People, page 37-38 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
|
|
|
|
|
|
|
Business ethics and compliance |
||||||
GRI 3: Material Topics 2021 |
3-3 |
Management of material topics |
• |
Business ethics and compliance, page 39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliance |
|
GRI 205: Anti-corruption 2016 |
205-3 |
Confirmed incidents of corruption and actions taken |
• |
Business ethics and compliance, page 41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcomplianceachievements2023 |
|
GRI 206: Anti-competitive behavior 2016 |
206-1 |
Legal actions for anti-competitive behavior, anti-trust, and monopoly practices |
• |
Business ethics and compliance, page 41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcomplianceachievements2023 |
|
Own indicator |
– |
IT security training |
• |
Business ethics and compliance, page 41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcomplianceachievements2023 |
|
Own indicator |
– |
Whistleblower training |
• |
Business ethics and compliance, page 41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcomplianceachievements2023 |
|